Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 53, Iss. 9, 2013-09 ,pp. : 955-961

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers

By Huang H.-L. A.   Vaidyanathan S.   Yeh C.-M.   Bizot M.-N.   Dieterich H. A.   Dole W. P.   Howard D.  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2449-2456

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the Effects of Food on the Single‐Dose Pharmacokinetics of Trametinib, a First‐in‐Class MEK Inhibitor, in Patients with Cancer

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 53, Iss. 9, 2013-09 ,pp. : 946-954

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses

By Kienzler J.-L.   Queille-Roussel C.   Mugglestone C.   Ortonne J.-P.   Larnier C.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1293-1302

Informa Healthcare

Access to resources Recommend Favorite

Response to in vitro and physiologically‐based pharmacokinetic assessment of the drug–drug interaction potential of canagliflozin

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 2, 2018-02 ,pp. : 392-393

John Wiley & Sons Inc

Access to resources Recommend Favorite